However, the viral infections also are related with diseases in the CNS characterized by the presence of leukocyte infiltration and inflammation, inducing a progressive damage [1], such as the progressive multifocal leukoencephalopathy with the John Cunningham virus (JC), AIDS-related dementia complex observed in HIV-1-infected patients, neurodevelopmental sequelae (mental retardation, cerebral palsy, and sensorineural hearing loss) caused by congenital cytomegalovirus (CMV) infection or cerebral mass lesions in immunocompromised adults CMV-infected, and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) that affects the human T-cell lymphotropic virus type 1 (HTLV-1)-infected individuals
doi:10.3945/ajcn.112.049965
The Medicare GLP-1 Bridge Program is a temporary program that helps eligible people with Medicare Part D access certain GLP-1 weight-loss medications for $50 per month
PlexusDx Precision Peptide Genetic Test reveals these predispositions to support a more informed discussion with your healthcare provider about expected tolerability and dose adjustment strategy
Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite
